Active Pharmaceutical IngredientIP / EP / USP

Montelukast Sodium

Description

A leukotriene receptor antagonist that reduces airway inflammation and constriction. Provides once-daily control for asthma and seasonal allergy symptoms.

Applications

Formulated into tablets and chewable tablets for asthma control and allergic rhinitis management.

Specifications

Therapeutic ClassRespiratory
AppearanceOff-White To Light Yellow Powder
Assay / Purity98.0–102.0%
SolubilityFreely Soluble In Water/Ethanol
GradeIP / USP / EP
Manufacturing ComplianceWHO-GMP / EU-GMP / USFDA

Get a tailored quotation for Montelukast Sodium within 24 business hours.

Request QuoteWhatsApp Enquiry

Response within 24 business hours